RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana

Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Renovaro Biosciences Inc. (the “Company”) (NasdaqCM: RENB) with GEDi Cube Intl Ltd. pursuant to which, all of GEDi Cube’s outstanding equity interests will be exchanged for shares of Renovaro common stock, with GEDi Cube equity holders expected to own approximately 50% of the combined company, subject to certain adjustments. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([e-mail]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-renb/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240110701810/en/

The Renovaro Inc. Aktie Stock at the time of publication of the news with a fall of -1,57 % to 4,40USD on Nasdaq stock exchange (10. Januar 2024, 22:30 Uhr).